|
1
|
Jiang X, Li Q, Zhang S, Song C and Zheng
P: Long noncoding RNA GIHCG induces cancer progression and
chemoresistance and indicates poor prognosis in colorectal cancer.
Onco Targets Ther. 12:1059–1070. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Liu L and Xie D, Xie H, Huang W, Zhang J,
Jin W, Jiang W and Xie D: ARHGAP10 inhibits the proliferation and
metastasis of CRC cells via blocking the activity of RhoA/AKT
signaling pathway. Onco Targets Ther. 12:11507–11516. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Nguyen LH, Goel A and Chung DC: Pathways
of colorectal carcinogenesis. Gastroenterology. 158:291–302. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Peng W, He D, Shan B, Wang J, Shi W, Zhao
W, Peng Z, Luo Q, Duan M, Li B, et al: LINC81507 act as a competing
endogenous RNA of miR-199b-5p to facilitate NSCLC proliferation and
metastasis via regulating the CAV1/STAT3 pathway. Cell Death Dis.
10:5332019. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Abedini P, Fattahi A, Agah S, Talebi A,
Beygi AH, Amini SM, Mirzaei A and Akbari A: Expression analysis of
circulating plasma long noncoding RNAs in colorectal cancer: The
relevance of lncRNAs ATB and CCAT1 as potential clinical hallmarks.
J Cell Physiol. 234:22028–22033. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ye C, Shen Z, Wang B, Li Y, Li T, Yang Y,
Jiang K, Ye Y and Wang S: A novel long non-coding RNA lnc-GNAT1-1
is low expressed in colorectal cancer and acts as a tumor
suppressor through regulating RKIP-NF-κB-Snail circuit. J Exp Clin
Cancer Res. 35:1872016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Huang L, Lin H, Kang L, Huang P, Huang J,
Cai J, Xian Z, Zhu P, Huang M, Wang L, et al: Aberrant expression
of long noncoding RNA SNHG15 correlates with liver metastasis and
poor survival in colorectal cancer. J Cell Physiol. 234:7032–7039.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sun X, Bai Y, Yang C, Hu S, Hou Z and Wang
G: Long noncoding RNA SNHG15 enhances the development of colorectal
carcinoma via functioning as a ceRNA through
miR-141/SIRT1/Wnt/β-catenin axis. Artif Cells Nanomed Biotechnol.
47:2536–2544. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zheng K and Zhang TK: LncRNA LINC00963
promotes proliferation and migration through the miR-124-3p/FZD4
pathway in colorectal cancer. Eur Rev Med Pharmacol Sci.
24:7634–7644. 2020.PubMed/NCBI
|
|
10
|
Balacescu O, Sur D, Cainap C, Visan S,
Cruceriu D, Manzat-Saplacan R, Muresan MS, Balacescu L, Lisencu C
and Irimie A: The impact of miRNA in colorectal cancer progression
and its liver metastases. Int J Mol Sci. 19:37112018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lei K, Liang X, Gao Y, Xu B, Xu Y, Li Y,
Tao Y, Shi W and Liu J: Lnc-ATB contributes to gastric cancer
growth through a MiR-141-3p/TGFβ2 feedback loop. Biochem Biophys
Res Commun. 484:514–521. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hannafon BN, Cai A, Calloway CL, Xu YF,
Zhang R, Fung KM and Ding WQ: miR-23b and miR-27b are oncogenic
microRNAs in breast cancer: Evidence from a CRISPR/Cas9 deletion
study. BMC Cancer. 19:6422019. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yan L, You WQ, Sheng NQ, Gong JF, Hu LD,
Tan GW, Chen HQ and Wang ZG: A CREB1/miR-433 reciprocal feedback
loop modulates proliferation and metastasis in colorectal cancer.
Aging (Albany NY). 10:3774–3793. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li P, Xue WJ, Feng Y and Mao QS:
MicroRNA-205 functions as a tumor suppressor in colorectal cancer
by targeting cAMP responsive element binding protein 1 (CREB1). Am
J Transl Res. 7:2053–2059. 2015.PubMed/NCBI
|
|
15
|
Chen L, Gao H, Liang J, Qiao J, Duan J,
Shi H, Zhen T, Li H, Zhang F, Zhu Z and Han A: miR-203a-3p promotes
colorectal cancer proliferation and migration by targeting PDE4D.
Am J Cancer Res. 8:2387–2401. 2018.PubMed/NCBI
|
|
16
|
Zhang H, Zhu M, Shan X, Zhou X, Wang T,
Zhang J, Tao J, Cheng W, Chen G, Li J, et al: A panel of
seven-miRNA signature in plasma as potential biomarker for
colorectal cancer diagnosis. Gene. 687:246–254. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Jiang J, Ma B, Li X, Jin W, Han C, Wang L
and Wang H: miR-1281, a p53-responsive microRNA, impairs the
survival of human osteosarcoma cells upon ER stress via targeting
USP39. Am J Cancer Res. 8:1764–1774. 2018.PubMed/NCBI
|
|
18
|
Liu G, Jiang Z, Qiao M and Wang F:
Lnc-GIHCG promotes cell proliferation and migration in gastric
cancer through miR-1281 adsorption. Mol Genet Genomic Med.
7:e7112019. View
Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yan S, Han B, Gao S, Wang X, Wang Z, Wang
F, Zhang J, Xu D and Sun B: Exosome-encapsulated microRNAs as
circulating biomarkers for colorectal cancer. Oncotarget.
8:60149–60158. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Bertero L, Massa F, Metovic J, Zanetti R,
Castellano I, Ricardi U, Papotti M and Cassoni P: Eighth edition of
the UICC classification of malignant tumours: An overview of the
changes in the pathological TNM classification criteria-what has
changed and why? Virchows Arch. 472:519–531. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Amin MB, Greene FL, Edge SB, Compton CC,
Gershenwald JE, Brookland RK, Meyer L, Gress DM, Byrd DR and
Winchester DP: The eighth edition AJCC cancer staging manual:
Continuing to build a bridge from a population-based to a more
‘personalized’ approach to cancer staging. CA Cancer J Clin.
67:93–99. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Paraskevopoulou MD, Vlachos IS, Karagkouni
D, Georgakilas G, Kanellos I, Vergoulis T, Zagganas K, Tsanakas P,
Floros E, Dalamagas T and Hatzigeorgiou AG: DIANA-LncBase v2:
Indexing microRNA targets on non-coding transcripts. Nucleic Acids
Res. 44(D1): D231–D238. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Agarwal V, Bell GW, Nam JW and Bartel DP:
Predicting effective microRNA target sites in mammalian mRNAs.
Elife. 4:e050052015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Peng WX, Koirala P and Mo YY:
LncRNA-mediated regulation of cell signaling in cancer. Oncogene.
36:5661–5667. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhou Y, Yin L, Li H, Liu LH and Xiao T:
The LncRNA LINC00963 facilitates osteosarcoma proliferation and
invasion by suppressing miR-204-3p/FN1 axis. Cancer Biol Ther.
20:1141–1148. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wu JH, Tian XY, An QM, Guan XY and Hao CY:
LINC00963 promotes hepatocellular carcinoma progression by
activating PI3K/AKT pathway. Eur Rev Med Pharmacol Sci.
22:1645–1652. 2018.PubMed/NCBI
|
|
28
|
Lee SP, Hsieh PL, Fang CY, Chu PM, Liao
YW, Yu CH, Yu CC and Tsai LL: LINC00963 promotes cancer stemness,
metastasis, and drug resistance in head and neck carcinomas via
ABCB5 regulation. Cancers (Basel). 12:10732020. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wang L, Han S, Jin G, Zhou X, Li M, Ying
X, Wang L, Wu H and Zhu Q: Linc00963: A novel, long non-coding RNA
involved in the transition of prostate cancer from
androgen-dependence to androgen-independence. Int J Oncol.
44:2041–2049. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ganju A, Khan S, Hafeez BB, Behrman SW,
Yallapu MM, Chauhan SC and Jaggi M: miRNA nanotherapeutics for
cancer. Drug Discov Today. 22:424–432. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Fan LY, Shi KY, Xu D, Ren LP, Yang P,
Zhang L, Wang F and Shao GL: LncRNA GIHCG regulates microRNA-1281
and promotes malignant progression of breast cancer. Eur Rev Med
Pharmacol Sci. 23:10842–10850. 2019.PubMed/NCBI
|
|
32
|
Pignot G, Cizeron-Clairac G, Vacher S,
Susini A, Tozlu S, Vieillefond A, Zerbib M, Lidereau R, Debre B,
Amsellem-Ouazana D and Bieche I: microRNA expression profile in a
large series of bladder tumors: Identification of a 3-miRNA
signature associated with aggressiveness of muscle-invasive bladder
cancer. Int J Cancer. 132:2479–2491. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wang H, Wang G, Gao Y, Zhao C, Li X, Zhang
F, Jiang C and Wu B: Lnc-SNHG1 activates the TGFBR2/SMAD3 and
RAB11A/Wnt/β-catenin pathway by sponging MiR-302/372/373/520 in
invasive pituitary tumors. Cell Physiol Biochem. 48:1291–1303.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Jiao H, Jiang S, Wang H, Li Y and Zhang W:
Upregulation of LINC00963 facilitates melanoma progression through
miR-608/NACC1 pathway and predicts poor prognosis. Biochem Biophys
Res Commun. 504:34–39. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Sun F, Wu K, Yao Z, Mu X, Zheng Z, Sun M,
Wang Y, Liu Z and Zhu Y: Long noncoding RNA LINC00963 induces NOP2
expression by sponging tumor suppressor miR-542-3p to promote
metastasis in prostate cancer. Aging (Albany NY). 12:11500–11516.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zhang N, Zeng X, Sun C, Guo H, Wang T, Wei
L, Zhang Y, Zhao J and Ma X: LncRNA LINC00963 promotes
tumorigenesis and radioresistance in breast cancer by sponging
miR-324-3p and inducing ACK1 expression. Mol Ther Nucleic Acids.
18:871–881. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Wu Z, Wang W, Wang Y, Wang X, Sun S, Yao
Y, Zhang Y and Ren Z: Long noncoding RNA LINC00963 promotes breast
cancer progression by functioning as a molecular sponge for
microRNA-625 and thereby upregulating HMGA1. Cell Cycle.
19:610–624. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Li Y, Ma C, Zhou T, Liu Y, Sun L and Yu Z:
TRIM65 negatively regulates p53 through ubiquitination. Biochem
Biophys Res Commun. 473:278–282. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Wang XL, Shi WP, Shi HC, Lu SC, Wang K,
Sun C, He JS, Jin WG, Lv XX, Zou H and Shu YS: Knockdown of TRIM65
inhibits lung cancer cell proliferation, migration and invasion: A
therapeutic target in human lung cancer. Oncotarget. 7:81527–81540.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Yang YF, Zhang MF, Tian QH and Zhang CZ:
TRIM65 triggers β-catenin signaling via ubiquitylation of Axin1 to
promote hepatocellular carcinoma. J Cell Sci. 130:3108–3115.
2017.PubMed/NCBI
|
|
41
|
Chen D, Li Y, Zhang X, Wu H, Wang Q, Cai
J, Cui Y, Liu H, Lan P, Wang J, et al: Ubiquitin ligase TRIM65
promotes colorectal cancer metastasis by targeting ARHGAP35 for
protein degradation. Oncogene. 38:6429–6444. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Hu G, Liu N, Wang H, Wang Y and Guo Z:
LncRNA LINC01857 promotes growth, migration, and invasion of glioma
by modulating miR-1281/TRIM65 axis. J Cell Physiol.
234:22009–22016. 2019. View Article : Google Scholar : PubMed/NCBI
|
